Pharming Group N.V. filed its 2025 Annual Report and Form 20-F with the SEC on April 2, 2026, making full-year financials and disclosures available to investors.
Key takeaways
Pharming Group N.V. filed its Annual Report for the year ended December 31, 2025.
Company filed its 2025 Annual Report on Form 20-F with the SEC.
Annual Report accessible at annualreport.pharming.com and Pharming.com Investors/Financial documents.
Form 20-F available under Investors/SEC filings on Pharming.com and SEC website.